WallStreetZenWallStreetZen

NASDAQ: SCLX
Scilex Holding Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SCLX

Based on 1 analyst offering 12 month price targets for Scilex Holding Co

Min Forecast
$630.00+12,970.54%
Avg Forecast
$630.00+12,970.54%
Max Forecast
$630.00+12,970.54%

Should I buy or sell SCLX stock?

Based on 1 analyst offering ratings for Scilex Holding Co.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SCLX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SCLX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SCLX stock forecasts and price targets.

SCLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-02

1 of 1

Forecast return on equity

Is SCLX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is SCLX forecast to generate an efficient return on assets?

Company
-194.1%
Industry
19.36%
SCLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCLX earnings per share forecast

What is SCLX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$24.48

SCLX revenue forecast

What is SCLX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$59.5M+17.29%
Avg 2 year Forecast
$62.5M+23.15%
SCLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCLX revenue growth forecast

How is SCLX forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
17.29%
Industry
6.2%
Market
55.62%
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCLX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
SCLX$4.82$630.00+12,970.54%Strong Buy
MIRA$1.21N/AN/A
AMRN$13.25$7.00-47.17%Strong Sell
OGN$10.04$17.33+72.64%Strong Buy
GRFS$8.87N/AN/A
View Top General Drug Manufacturer Stocks

Scilex Holding Co Stock Forecast FAQ

Is Scilex Holding Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SCLX) stock is to Strong Buy SCLX stock.

Out of 1 analyst, 1 (100%) are recommending SCLX as a Strong Buy, 0 (0%) are recommending SCLX as a Buy, 0 (0%) are recommending SCLX as a Hold, 0 (0%) are recommending SCLX as a Sell, and 0 (0%) are recommending SCLX as a Strong Sell.

If you're new to stock investing, here's how to buy Scilex Holding Co stock.

What is SCLX's earnings growth forecast for 2025-2025?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 109.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Scilex Holding Co's earnings in 2025 is -$74,510,000.

In 2025, SCLX is forecast to generate -$170,175,707 in earnings, with the lowest earnings forecast at -$170,175,707 and the highest earnings forecast at -$170,175,707.

What is SCLX's revenue growth forecast for 2025-2026?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 17.29% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Scilex Holding Co's revenue in 2025 is $50,710,000.On average, 1 Wall Street analysts forecast SCLX's revenue for 2025 to be $413,482,477, with the lowest SCLX revenue forecast at $413,482,477, and the highest SCLX revenue forecast at $413,482,477.

In 2026, SCLX is forecast to generate $434,128,794 in revenue, with the lowest revenue forecast at $434,128,794 and the highest revenue forecast at $434,128,794.

What is SCLX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SCLX) forecast ROA is -194.1%, which is lower than the forecast US Drug Manufacturers - General industry average of 19.36%.

What is SCLX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SCLX price target, the average SCLX price target is $630.00, with the highest SCLX stock price forecast at $630.00 and the lowest SCLX stock price forecast at $630.00.

The Wall Street analyst predicted that Scilex Holding Co's share price could reach $630.00 by Apr 2, 2026. The average Scilex Holding Co stock price prediction forecasts a potential upside of 12,970.54% from the current SCLX share price of $4.82.

What is SCLX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: SCLX) Scilex Holding Co's current Earnings Per Share (EPS) is -$14.16. In 2025, SCLX's EPS is forecast to hit -$24.48 (min: -$24.48, max: -$24.48).

What is SCLX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SCLX) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.